Search

Luk H. Vandenberghe, PhD, along with collaborator and lead author Rob Collin, PhD, of Radboud University Medical Center, has been selected to receive the 2017 Ed Gollob Board of Directors’ Award from the Foundation Fighting Blindness (FFB). This award is presented annually in recognition of...

Findings may have significant therapeutic implications for AMD, the most common cause of elderly blindness in the developed world Boston, Mass. — A compound of specific bioactive products from a major family of enzymes reduced the severity of age-related macular degeneration (AMD) in a preclinical...

The National Institutes of Health (NIH) funded Schepens Eye Research Institute of Mass. Eye and Ear’s P30 core grant competitive renewal (PI: Pablo Argüeso, PhD) at $3,940,010 over five years. This critical funding supports four shared core resources at 20 Staniford Street: Animal Resource, Flow...

Michael A. Sandberg, PhD retired from Mass. Eye and Ear at the end of September. Dr. Sandberg was recruited by Dr. Eliot Berson to the Berman-Gund Laboratory for the Study of Retinal Degenerations and the Electroretinography Service (now the Inherited Retinal Disorders Service) at Massachusetts Eye...

The Massachusetts Lions Eye Research Fund awarded 2017-18 grants to several Harvard Ophthalmology affiliates and Boston-area research institutions. Each institution received $160,000, which supported the following projects: Mass. Eye and Ear: Kip Connor, PhD: “Targeting the immune system in retinal...

Maan Alkharashi, MD, received funds in the in the amount of $1750 per patient over one year for his involvement in the clinical study with the Pediatric Eye Disease Investigator Group, "Binocular Dig Rush Game Treatment for Amblyopia” funded by the National Eye Institute of the National Institutes...

The following individuals have matched into the Harvard Ophthalmology Residency Program as the class of 2022: Sila Bal, University of Pennsylvania-Perelman School of Medicine Carolina Chiou, Harvard Medical School Jacob Cox, Johns Hopkins University School of Medicine Inês Laíns, MD, Faculty of...

New nonprofit organization will bring treatments to clinical trial for people at risk for blindness due to ultra-rare inherited retinal diseases. Boston, Mass. — Scientists and advocates today announced the formation of Odylia Therapeutics, a nonprofit corporation dedicated to creating gene...

Luk Vandenberghe, PhD , Director of the Grousbeck Gene Therapy Center at Mass. Eye and Ear and Assistant Professor of Ophthalmology at Harvard Medical School, will receive the American Society of Gene and Cell Therapy (ASGCT) Outstanding New Investigator Award — one of the Society’s highest honors...

Neena Haider, PhD , Associate Professor of Ophthalmology, was invited by the American Macular Degeneration Foundation (AMDF) to lobby Congress to increase support for the National Institutes of Health (NIH) and National Eye Institute. In March, she met with Senator Elizabeth Warren, Congressmen Joe...